Coalition pushes back on PhRMA’s claims about drug prices

A coalition of health care providers, insurers, seniors and others is pushing back on some of the latest claims by the Pharmaceutical Research and Manufacturers of America that incorrectly blame hospitals for the rising price of drugs. The latest installment of the Campaign for Sustainable Rx Pricing’s “Second Opinion” series highlights how hospitals are subject to fixed reimbursements for the vast majority of care they provide, and the “true driver behind the rising costs is PhRMA’s willingness to do anything for an extra dollar, even if it means forcing patients to choose between paying for the medicines they need and their daily life necessities.” CSRxP, of which the AHA is a founding member, said it will continue to fact check PhRMA’s false claims and move forward with patient-focused solutions to increase transparency, promote competition and ensure a drug’s price is based on how well it works for patients.